1. De novo a-to-i rna editing discovery in lncrna
- Author
-
Domenico Alessandro Silvestris, Chiara Scopa, Franco Locatelli, Sara Hanchi, and Angela Gallo
- Subjects
0301 basic medicine ,Cancer Research ,RNA editing ,brain ,Computational biology ,lcsh:RC254-282 ,Article ,Transcriptome ,03 medical and health sciences ,0302 clinical medicine ,Adenosine deaminase ,lncRNA ,medicine ,Inosine ,biology ,glioblastoma ,RNA ,Human brain ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Adenosine ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA ,030220 oncology & carcinogenesis ,ADAR ,biology.protein ,medicine.drug - Abstract
Background: Adenosine to inosine (A-to-I) RNA editing is the most frequent editing event in humans. It converts adenosine to inosine in double-stranded RNA regions (in coding and non-coding RNAs) through the action of the adenosine deaminase acting on RNA (ADAR) enzymes. Long non-coding RNAs, particularly abundant in the brain, account for a large fraction of the human transcriptome, and their important regulatory role is becoming progressively evident in both normal and transformed cells. Results: Herein, we present a bioinformatic analysis to generate a comprehensive inosinome picture in long non-coding RNAs (lncRNAs), using an ad hoc index and searching for de novo editing events in the normal brain cortex as well as in glioblastoma, a highly aggressive human brain cancer. We discovered >, 10,000 new sites and 335 novel lncRNAs that undergo editing, never reported before. We found a generalized downregulation of editing at multiple lncRNA sites in glioblastoma samples when compared to the normal brain cortex. Conclusion: Overall, our study discloses a novel layer of complexity that controls lncRNAs in the brain and brain cancer.
- Published
- 2020